Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
June 17, 2014 07:30 ET
|
Societal CDMO, Inc.
MALVERN, Pa., June 17, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
Recro Pharma Reports First Quarter 2014 Financial Results
May 12, 2014 07:30 ET
|
Societal CDMO, Inc.
MALVERN, Pa., May 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
Recro Pharma Announces New Board Members
March 13, 2014 13:23 ET
|
Societal CDMO, Inc.
MALVERN, Pa., March 13, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today...
Recro Pharma Announces Closing of Initial Public Offering
March 12, 2014 16:05 ET
|
Societal CDMO, Inc.
MALVERN, Pa., March 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...
Recro Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
March 11, 2014 08:00 ET
|
Societal CDMO, Inc.
MALVERN, Pa., March 11, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...
Recro Pharma Announces Pricing of Its Initial Public Offering
March 06, 2014 20:44 ET
|
Societal CDMO, Inc.
MALVERN, Pa., March 6, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...